137 related articles for article (PubMed ID: 19954178)
1. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives.
Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ
Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
[TBL] [Abstract][Full Text] [Related]
3. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells.
Hopkins JE; Naisbitt DJ; Humphreys N; Dearman RJ; Kimber I; Park BK
Toxicology; 2005 Jan; 206(2):221-31. PubMed ID: 15588915
[TBL] [Abstract][Full Text] [Related]
4. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.
Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884
[TBL] [Abstract][Full Text] [Related]
5. Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation.
Naisbitt DJ; Farrell J; Gordon SF; Maggs JL; Burkhart C; Pichler WJ; Pirmohamed M; Park BK
Mol Pharmacol; 2002 Sep; 62(3):628-37. PubMed ID: 12181439
[TBL] [Abstract][Full Text] [Related]
6. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo.
Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C
Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600
[TBL] [Abstract][Full Text] [Related]
7. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.
Naisbitt DJ; Gordon SF; Pirmohamed M; Burkhart C; Cribb AE; Pichler WJ; Park BK
Br J Pharmacol; 2001 May; 133(2):295-305. PubMed ID: 11350866
[TBL] [Abstract][Full Text] [Related]
8. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis.
Lavergne SN; Whitaker P; Peckham D; Conway S; Park BK; Naisbitt DJ
Chem Res Toxicol; 2010 Jun; 23(6):1009-11. PubMed ID: 20481640
[TBL] [Abstract][Full Text] [Related]
9. Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity.
Depta JP; Altznauer F; Gamerdinger K; Burkhart C; Weltzien HU; Pichler WJ
J Allergy Clin Immunol; 2004 Mar; 113(3):519-27. PubMed ID: 15007356
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.
Rieder MJ; Uetrecht J; Shear NH; Spielberg SP
J Pharmacol Exp Ther; 1988 Feb; 244(2):724-8. PubMed ID: 3346843
[TBL] [Abstract][Full Text] [Related]
11. [BCG-induced T cell anergy and its activation by IL-4].
Nishioka Y; Nakanishi K; Sugita M
Arerugi; 1998 May; 47(5):533-42. PubMed ID: 9656576
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
[TBL] [Abstract][Full Text] [Related]
14. Drug presentation to T cells.
Naisbitt DJ; Pirmohamed M; Park BK
J Allergy Clin Immunol; 2005 Apr; 115(4):876-7; author reply 877-8. PubMed ID: 15806015
[No Abstract] [Full Text] [Related]
15. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling.
Sanderson JP; Naisbitt DJ; Farrell J; Ashby CA; Tucker MJ; Rieder MJ; Pirmohamed M; Clarke SE; Park BK
J Immunol; 2007 May; 178(9):5533-42. PubMed ID: 17442935
[TBL] [Abstract][Full Text] [Related]
16. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
Burkhart C; von Greyerz S; Depta JP; Naisbitt DJ; Britschgi M; Park KB; Pichler WJ
Br J Pharmacol; 2001 Feb; 132(3):623-30. PubMed ID: 11159714
[TBL] [Abstract][Full Text] [Related]
17. A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals.
Engler OB; Strasser I; Naisbitt DJ; Cerny A; Pichler WJ
Toxicology; 2004 Apr; 197(1):47-56. PubMed ID: 15003333
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
19. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
[TBL] [Abstract][Full Text] [Related]
20. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
Hess DA; Bird IA; Almawi WY; Rieder MJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
